Company Profile

Masimo Stock Price, News & Analysis

Ticker:
MASI
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
Headquartered in the United States and listed on NASDAQ, Masimo is followed within the biotech universe for its exposure to catalyst-driven execution.

Stock performance

179.95 USD (+0.01%)

Close

Last updated: June 9, 2026 at 00:00

9.42B USD

Market cap

Why the stock is moving

MASI is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Masimo is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Masimo is followed within the biotech universe for its exposure to catalyst-driven execution.

Business Model Characteristics

Masimo follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.

Position Within the Biotechnology Landscape

Compared with more mature healthcare peers, Masimo sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.

Future catalysts

Recent news

The five most recent feed items are shown below in reverse chronological order.

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    Frequently Asked Questions

    What is the current stock price of Masimo (MASI)?

    Masimo (MASI) most recently closed at 179.95 USD, a +0.01% move versus the previous session.

    What is the market cap of Masimo (MASI)?

    Masimo currently has a market capitalization of 9.42B USD on BioPharmSignal.

    What does Masimo do?

    Masimo is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    On which exchange is MASI stock listed?

    Masimo (MASI) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Masimo is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.

    What is Masimo?

    Masimo is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.

    Which conditions is Masimo targeting with Masimo?

    Masimo is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

    What is Investors?

    Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.